新型冠状病毒肺炎(COVID-19)药物防治研究进展

Pharmaceuticals research progress on prevention and treatment of COVID-19

新型冠状病毒肺炎(COVID-19)是一种新型冠状病毒感染的肺炎,伴有发热、咳嗽、呼吸困难、低氧血症、脓毒症休克、代谢性酸中毒和出凝血功能障碍等症状。目前治疗尚无特效手段,中西医结合的药物治疗是最主要的治疗手段。本文综述了COVID-19药物治疗的研究进展,并提出相关药物可能的作用机制,为抗COVID-19新药和疫苗研发提供指导。

COVID-19 is a new type of coronavirus-infected pneumonia,accompanied by fever,cough,dyspnea,hypoxemia,sepsis shock,metabolic acidosis,and coagulation dysfunction.At present,there are no special treatments,and the combination of traditional Chinese medicine and western medicine is the main treatment approach.This article reviews the research progress of COVID-19 drug therapy,and proposes possible mechanisms of action of related pharmaceuticals,providing guidance for the development of new anti-COVID-19 pharmaceuticals and vaccines.